Facebook Twitter

PARADIGM NAMES PRESIDENT, CEO

SHARE PARADIGM NAMES PRESIDENT, CEO

Martin M. McGlynn, president of the Pharmaceutical Products Division of Ohmeda, a New Jersey-based company, is the new president and chief executive officer of Paradigm Biosciences Inc., 2401 Foothill Drive.

"Martin McGlynn brings to Paradigm strategic business management and operating expertise based on more than 25 years in the pharmaceutical industry," said Raymond Daynes, Paradigm chairman.